Basilea Pharmaceutica AG
BPMUF
$54.00
$1.172.22%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 133.21M | 142.90M | 70.07M | 69.80M | 71.17M |
| Total Receivables | 64.21M | 68.88M | 54.47M | 54.26M | 69.05M |
| Inventory | 34.88M | 37.42M | 34.92M | 34.78M | 31.36M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 11.49M | 12.32M | 13.05M | 13.00M | 9.09M |
| Total Current Assets | 243.78M | 261.52M | 172.51M | 171.85M | 180.68M |
|
|
|||||
| Total Current Assets | 243.78M | 261.52M | 172.51M | 171.85M | 180.68M |
| Net Property, Plant & Equipment | 20.94M | 22.47M | 21.60M | 21.52M | 24.41M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 412.70K | 442.80K | 526.40K | 524.40K | 650.80K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 19.31M | 20.72M | 15.32M | 15.26M | 52.30K |
| Total Assets | 284.45M | 305.15M | 209.95M | 209.15M | 205.79M |
|
|
|||||
| Total Accounts Payable | 12.68M | 13.60M | 12.77M | 12.72M | 6.94M |
| Total Accrued Expenses | 23.73M | 25.45M | 12.80M | 12.75M | 15.56M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.28M | 2.44M | 2.29M | 2.29M | 20.80M |
| Total Finance Division Other Current Liabilities | 11.60M | 12.44M | 14.19M | 14.13M | 13.22M |
| Total Other Current Liabilities | 11.60M | 12.44M | 14.19M | 14.13M | 13.22M |
| Total Current Liabilities | 50.27M | 53.93M | 42.04M | 41.88M | 56.52M |
|
|
|||||
| Total Current Liabilities | 50.27M | 53.93M | 42.04M | 41.88M | 56.52M |
| Long-Term Debt | 105.84M | 113.54M | 106.48M | 106.07M | 113.36M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 15.12M | 16.22M | 16.36M | 16.30M | 18.57M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 23.83M | 25.57M | 26.39M | 26.29M | 29.22M |
| Total Liabilities | 195.07M | 209.26M | 191.27M | 190.54M | 217.67M |
|
|
|||||
| Common Stock & APIC | 1.17B | 1.26B | 1.18B | 1.17B | 1.25B |
| Retained Earnings | -1.02B | -1.09B | -1.09B | -1.09B | -1.19B |
| Treasury Stock & Other | -62.29M | -66.82M | -67.91M | -67.65M | -76.26M |
| Total Common Equity | 89.39M | 95.89M | 18.68M | 18.61M | -11.88M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 89.39M | 95.89M | 18.68M | 18.61M | -11.88M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 89.39M | 95.89M | 18.68M | 18.61M | -11.88M |
|
|
|||||
